COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Cerebral Palsy Adult Transition Longitudinal Study

Conditions: Cerebral Palsy

First Posted Date: 2014-05-13

Last Posted Date: 2021-01-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 72

Registration Number: NCT02137005

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Reducing Youth Access to Firearms Through the Health Care Setting

Not Applicable

Completed

Conditions: Youth Access to Guns in the Home

Interventions: Behavioral: Means restriction counseling

First Posted Date: 2014-05-12

Last Posted Date: 2019-04-30

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 76

Registration Number: NCT02136225

Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach

Phase 4

Completed

Conditions: Hypotension
Kidney Injury

Interventions: Drug: Plasmalyte 3ml/kg/hr group
Drug: Plasmalyte 6ml/kg/hr group

First Posted Date: 2014-05-09

Last Posted Date: 2020-03-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 40

Registration Number: NCT02135146

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Accountable Care Organizations/ Public Health Collaborative

Not Applicable

Completed

Conditions: Immunization Reminder System

Interventions: Other: Centralized Reminder/Recall (R/R)
Other: Practice-based Reminder/Recall

First Posted Date: 2014-05-08

Last Posted Date: 2017-09-29

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 78354

Registration Number: NCT02133391

Locations: 🇺🇸
Children's Outcomes Research Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.

Completed

Conditions: Essential Tremor
Multiple System Atrophy
Parkinson Disease
Corticobasal Degeneration
Supranuclear Palsy, Progressive

First Posted Date: 2014-05-06

Last Posted Date: 2021-06-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 81

Registration Number: NCT02132052

Locations: 🇺🇸
University Of Colorado. Denver, MEG Lab, Aurora, Colorado, United States

Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

Not Applicable

Completed

Conditions: Cognitive Impairment
Cardiovascular Disease
Executive Dysfunction
Endothelial Dysfunction

Interventions: Drug: Leuprolide acetate
Drug: Placebo
Drug: Estradiol
Drug: Medroxyprogesterone

First Posted Date: 2014-04-24

Last Posted Date: 2022-01-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 17

Registration Number: NCT02122198

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
🇺🇸
University of Colorado Boulder Intermountain Neuroimaging Consortium, Boulder, Colorado, United States

Treatment of Tracheostomy Granulomas

Phase 4

Completed

Conditions: Tracheostomy
Granuloma

Interventions: Drug: Hydrocortisone Butyrate Cream, 1.0%
Drug: Betadine
Drug: Silver Nitrate

First Posted Date: 2014-04-17

Last Posted Date: 2021-09-13

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 26

Registration Number: NCT02116608

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

Phase 1

Completed

Conditions: Shingles
Herpes Zoster

Interventions: Biological: Zostavax
Biological: HZ/su vaccine
Biological: Placebo

First Posted Date: 2014-04-15

Last Posted Date: 2020-07-08

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 160

Registration Number: NCT02114333

Locations: 🇺🇸
Pediatric Infectious Diseases and Clinical Trials, Universtiy of Colorado School of Medicine, Aurora, Colorado, United States

Phase I Nicotinic Agonist Treatment Trial for Autism

Phase 1

Terminated

Conditions: Autism

Interventions: Other: placebo
Drug: DMXB-A 150 mg
Drug: DMXB-A 75 mg

First Posted Date: 2014-04-11

Last Posted Date: 2016-06-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 2

Registration Number: NCT02111551

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Effects of an Adapted Ski/Snowboarding Program on Quality of Life in Children With Physical Disabilities

Completed

Conditions: Cerebral Palsy
Spinal Cord Injuries
Traumatic Brain Injuries
Physical Disability

First Posted Date: 2014-04-10

Last Posted Date: 2019-10-31

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 86

Registration Number: NCT02110290

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy